Display options
Cite
Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):e35-40doi: 10.1182/blood-2010-04-280347.
Oliveira, J. B., Bleesing, J. J., Dianzani, U., Fleisher, T. A., Jaffe, E. S., Lenardo, M. J., Rieux-Laucat, F., Siegel, R. M., Su, H. C., Teachey, D. T., & Rao, V. K. (2010). Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood, 116(14), e35-40. https://doi.org/10.1182/blood-2010-04-280347
Oliveira, Joao B, et al. "Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop." Blood vol. 116,14 (2010): e35-40. doi: https://doi.org/10.1182/blood-2010-04-280347
Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010 Oct 07;116(14):e35-40. doi: 10.1182/blood-2010-04-280347. Epub 2010 Jun 10. PMID: 20538792; PMCID: PMC2953894.
Copy Download .nbib Format: NLM
Share it on

Blood. 2010 Oct 07;116(14):e35-40. doi: 10.1182/blood-2010-04-280347. Epub 2010 Jun 10.

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Blood

Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey, V Koneti Rao

Affiliations

  1. Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. [email protected]

PMID: 20538792 PMCID: PMC2953894 DOI: 10.1182/blood-2010-04-280347

Abstract

Lymphadenopathy in children for which no infectious or malignant cause can be ascertained constitutes a challenging diagnostic dilemma. Autoimmune lymphoproliferative syndrome (ALPS) is a human genetic disorder of lymphocyte apoptosis resulting in an accumulation of lymphocytes and childhood onset chronic lymphadenopathy, splenomegaly, multilineage cytopenias, and an increased risk of B-cell lymphoma. In 1999, investigators at the National Institutes of Health (NIH) suggested criteria to establish the diagnosis of ALPS. Since then, with approximately 500 patients with ALPS studied worldwide, significant advances in our understanding of the disease have prompted the need for revisions to the existing diagnostic criteria and classification scheme. The rationale and recommendations outlined here stem from an international workshop held at NIH on September 21 and 22, 2009, attended by investigators from the United States, Europe, and Australia engaged in clinical and basic science research on ALPS and related disorders. It is hoped that harmonizing the diagnosis and classification of ALPS will foster collaborative research and better understanding of the pathogenesis of autoimmune cytopenias and B-cell lymphomas.

References

  1. Proc Natl Acad Sci U S A. 2007 May 22;104(21):8953-8 - PubMed
  2. Blood. 2010 Mar 18;115(11):2142-5 - PubMed
  3. Mod Pathol. 2004 Jan;17(1):131-5 - PubMed
  4. Haematologica. 2006 Apr;91(4):538-41 - PubMed
  5. Blood. 2009 Mar 26;113(13):3027-30 - PubMed
  6. Blood. 2005 Mar 15;105(6):2443-8 - PubMed
  7. J Allergy Clin Immunol. 2010 Apr;125(4):946-949.e6 - PubMed
  8. Hematology. 2006 Feb;11(1):15-23 - PubMed
  9. Science. 1995 Jun 2;268(5215):1347-9 - PubMed
  10. BMC Med Genet. 2007 Jul 02;8:41 - PubMed
  11. Lancet. 1996 Sep 14;348(9029):719-23 - PubMed
  12. Science. 2005 Mar 4;307(5714):1465-8 - PubMed
  13. Blood. 2006 Aug 15;108(4):1306-12 - PubMed
  14. Blood. 1997 Feb 15;89(4):1341-8 - PubMed
  15. N Engl J Med. 2004 Sep 30;351(14):1409-18 - PubMed
  16. J Clin Invest. 1992 Aug;90(2):334-41 - PubMed
  17. Nature. 2002 Sep 26;419(6905):395-9 - PubMed
  18. J Pediatr. 1967 Jun;70(6):891-9 - PubMed
  19. Blood. 2000 May 15;95(10):3176-82 - PubMed
  20. Cell. 1995 Jun 16;81(6):935-46 - PubMed
  21. J Clin Invest. 1996 Sep 1;98(5):1107-13 - PubMed
  22. Cell. 1999 Jul 9;98(1):47-58 - PubMed
  23. Am J Pathol. 1998 Nov;153(5):1541-50 - PubMed
  24. Blood. 1997 Apr 15;89(8):2871-9 - PubMed
  25. Immunity. 2010 Mar 26;32(3):291-5 - PubMed
  26. Clin Genet. 1974;5(5):379-86 - PubMed
  27. Am J Hum Genet. 1999 Apr;64(4):1002-14 - PubMed
  28. J Clin Invest. 2009 Oct;119(10):2976-89 - PubMed
  29. Annu Rev Immunol. 1999;17:221-53 - PubMed
  30. Nature. 1992 Mar 26;356(6367):314-7 - PubMed
  31. Blood. 1999 Oct 15;94(8):2575-82 - PubMed
  32. Pediatr Clin North Am. 2000 Dec;47(6):1291-310 - PubMed
  33. Blood. 2010 Jun 24;115(25):5164-9 - PubMed
  34. Annu Rev Immunol. 2006;24:321-52 - PubMed
  35. Curr Protoc Immunol. 2004 May;Chapter 3:Unit 3.17 - PubMed
  36. Ann Intern Med. 1999 Apr 6;130(7):591-601 - PubMed

MeSH terms

Publication Types

Grant support